Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Dec 23, 2015
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Award
Stock Option (right to purchase)
2015-12-22+200,000→ 200,000 totalExercise: $1.12Exp: 2025-12-21→ Common Stock, par value $0.001 per share (200,000 underlying)
Footnotes (1)
- [F1]On December 22, 2015 (the "Grant Date"), the Reporting Person was granted an option under the Company's 2015 Equity Compensation Plan (the "Plan") to purchase shares of the Issuer's common stock, subject to all of the terms and conditions of the Plan. This option vests as follows: 50,000 shares on the Grant Date, with the remaining 150,000 shares vesting in even increments of 12,500 shares quarterly over a period of 36 months.